<DOC>
	<DOCNO>NCT01045785</DOCNO>
	<brief_summary>The purpose study determine whether aspirin resistance impact cardiovascular event dialysis patient .</brief_summary>
	<brief_title>Investigation Platelet Function Aspirin Resistance Chronic Dialysis Patient</brief_title>
	<detailed_description>Dialysis patient inevitably suffer uremic bleeding although improvement dialysis care past decade . Physicians use check bleeding time surrogate marker uremic bleeding . However , bleed time n't accurate well know , poorly correlate clinical bleed surgical bleeding . Platelet function assay ( PFA ) newly develop method measure platelet aggregation vitro validate many sort platelet disorder . Recently , PFA also use evaluate aspirin responsiveness patient take aspirin . Our study aim investigate uremic thrombocytopathy via PFA dialysis patient Taiwan . Furthermore , study aspirin resistance dialysis patient .</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<criteria>dialysis &gt; 3 month Hb &gt; 10 g/dl &amp; Plt &gt; 10000 use medication interfere PFA except aspirin terminal disease malignancy active vasculitis</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2009</verification_date>
	<keyword>aspirin resistance , platelet function assay , dialysis , end stage renal disease</keyword>
</DOC>